Once-Daily, Subcutaneous Vosoritide Therapy in Children with Achondroplasia: A Randomised, Double-Blind, Phase 3, Placebo-Controlled, Multicentre Trial.|Citation only
Savarirayan, Day, et al.·Lancet·2020·209 citations·Pediatrics
Once-Daily, Subcutaneous Vosoritide Therapy in Children with Achondroplasia: A Randomised, Double-Blind, Phase 3, Placebo-Controlled, Multicentre Trial.|Citation only
Savarirayan, Day, et al.·Lancet·2020·209 citations·Pediatrics